GE HealthCare Technologies (GEHC) EBIT (2022 - 2026)

GE HealthCare Technologies (GEHC) has reported EBIT for 5 consecutive years, with $739.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 13.0% year-over-year to $739.0 million; the trailing twelve-month figure through Jun 2026 stood at $2.7 billion (down 0.94% YoY), and the FY2025 full-year result was $2.8 billion, up 5.26% from the prior year.
• EBIT improved to $739.0 million in Q2 2026 per GEHC's latest filing, from $515.0 million in the prior quarter.
• Across five years, EBIT topped out at $827.0 million in Q4 2025 and bottomed at $509.0 million in Q1 2022.
• Historically, EBIT has averaged $644.4 million across 5 years, with a median of $630.0 million in 2022.
• The sharpest annual moves came in 2025 and 2026: EBIT rose 16.48% in 2025, then dropped 18.12% in 2026.
• Over 5 years, EBIT stood at $777.0 million in 2022, then slipped by 11.33% to $689.0 million in 2023, then grew by 16.26% to $801.0 million in 2024, then grew by 3.25% to $827.0 million in 2025, then retreated by 10.64% to $739.0 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $739.0 million, $515.0 million, and $827.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.